Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Apr;68(4):441–443. doi: 10.1136/adc.68.4.441

How to get drugs into the respiratory tract.

C O'Callaghan 1
PMCID: PMC1029259  PMID: 8503663

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bisgaard H., Munck S. L., Nielsen J. P., Petersen W., Ohlsson S. V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet. 1990 Sep 15;336(8716):649–651. doi: 10.1016/0140-6736(90)92147-a. [DOI] [PubMed] [Google Scholar]
  2. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax. 1990 Oct;45(10):736–739. doi: 10.1136/thx.45.10.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clay M. M., Pavia D., Newman S. P., Clarke S. W. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax. 1983 Oct;38(10):755–759. doi: 10.1136/thx.38.10.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collis G. G., Cole C. H., Le Souëf P. N. Dilution of nebulised aerosols by air entrainment in children. Lancet. 1990 Aug 11;336(8711):341–343. doi: 10.1016/0140-6736(90)91880-j. [DOI] [PubMed] [Google Scholar]
  5. Ebden P., Jenkins A., Houston G., Davies B. H. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax. 1986 Nov;41(11):869–874. doi: 10.1136/thx.41.11.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Everard M. L., Clark A. R., Milner A. D. Drug delivery from holding chambers with attached facemask. Arch Dis Child. 1992 May;67(5):580–585. doi: 10.1136/adc.67.5.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Everard M. L., Clark A. R., Milner A. D. Drug delivery from jet nebulisers. Arch Dis Child. 1992 May;67(5):586–591. doi: 10.1136/adc.67.5.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Farrer M., Francis A. J., Pearce S. J. Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax. 1990 Oct;45(10):740–742. doi: 10.1136/thx.45.10.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gleeson J. G., Price J. F. Controlled trial of budesonide given by the nebuhaler in preschool children with asthma. BMJ. 1988 Jul 16;297(6642):163–166. doi: 10.1136/bmj.297.6642.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grigg J., Arnon S., Jones T., Clarke A., Silverman M. Delivery of therapeutic aerosols to intubated babies. Arch Dis Child. 1992 Jan;67(1 Spec No):25–30. doi: 10.1136/adc.67.1_spec_no.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Knowles M. R., Church N. L., Waltner W. E., Yankaskas J. R., Gilligan P., King M., Edwards L. J., Helms R. W., Boucher R. C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med. 1990 Apr 26;322(17):1189–1194. doi: 10.1056/NEJM199004263221704. [DOI] [PubMed] [Google Scholar]
  12. Le Souëf P. N. Validity of methods used to test airway responsiveness in children. Lancet. 1992 May 23;339(8804):1282–1284. doi: 10.1016/0140-6736(92)91602-5. [DOI] [PubMed] [Google Scholar]
  13. McElvaney N. G., Hubbard R. C., Birrer P., Chernick M. S., Caplan D. B., Frank M. M., Crystal R. G. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet. 1991 Feb 16;337(8738):392–394. doi: 10.1016/0140-6736(91)91167-s. [DOI] [PubMed] [Google Scholar]
  14. O'Callaghan C., Clark A. R., Milner A. D. Why nebulise for more than five minutes? Arch Dis Child. 1989 Sep;64(9):1270–1273. doi: 10.1136/adc.64.9.1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. O'Callaghan C., Hardy J., Stammers J., Stephenson T. J., Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Arch Dis Child. 1992 Jan;67(1 Spec No):20–24. doi: 10.1136/adc.67.1_spec_no.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. O'Callaghan C., Milner A. D., Swarbrick A. Spacer device with face mask attachment for giving bronchodilators to infants with asthma. BMJ. 1989 Jan 21;298(6667):160–161. doi: 10.1136/bmj.298.6667.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. O'Callaghan C. Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices. Thorax. 1990 Feb;45(2):109–111. doi: 10.1136/thx.45.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Priftis K., Milner A. D., Conway E., Honour J. W. Adrenal function in asthma. Arch Dis Child. 1990 Aug;65(8):838–840. doi: 10.1136/adc.65.8.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ruffin R. E., Kenworthy M. C., Newhouse M. T. Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther. 1978 Mar;23(3):338–345. doi: 10.1002/cpt1978233338. [DOI] [PubMed] [Google Scholar]
  20. Shak S., Capon D. J., Hellmiss R., Marsters S. A., Baker C. L. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9188–9192. doi: 10.1073/pnas.87.23.9188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Webb M. S., Milner A. D., Hiller E. J., Henry R. L. Nebulised beclomethasone dipropionate suspension. Arch Dis Child. 1986 Nov;61(11):1108–1110. doi: 10.1136/adc.61.11.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yuksel B., Greenough A., Maconochie I. Effective bronchodilator treatment by a simple spacer device for wheezy premature infants. Arch Dis Child. 1990 Jul;65(7):782–785. doi: 10.1136/adc.65.7.782. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES